The Economist (US), December 22nd, 1990
THE first new drug in 40 years for the treatment of African sleeping sickness has been approved for general use by America's Food and Drug Administration and the World Health Organisation. Ornidyl, made by an American pharmaceutical company, Marion Merrell Dow, has been nicknamed the "resurrection drug" because of its dramatic effects on some of the 600 or so patients who have already been treated with it in Africa. Most of them were near to death, yet recovered completely with, at worst, only minor side-effects.
The disease is caused by trypanosome parasites transmitted by tsetse flies. It...
HighBeam Research, Free Preview: 'Wake-up call. (sleeping sickness)'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
